Please login to the form below

Not currently logged in
Email:
Password:

NovoEight

This page shows the latest NovoEight news and features for those working in and with pharma, biotech and healthcare.

New data could unlock bigger market for Roche’s Hemlibra

New data could unlock bigger market for Roche’s Hemlibra

Novo Nordisk is developing a once-weekly version of its established NovoEight product - called N8-GP - that could be filed next year.

Latest news

  • US approval for Novo's Factor XIII drug Tretten US approval for Novo's Factor XIII drug Tretten

    In October, Novo secured US approval for NovoEight, a new long-acting Factor VIII for people with haemophilia A (turoctocog alfa), while it also has NN7999, a long-acting recombinant coagulation

  • Novo Nordisk wins US approval for haemophilia treatment Novo Nordisk wins US approval for haemophilia treatment

    US regulators have approved NovoEight, Novo Nordisk's new treatment for people with haemophilia A. ... The US approval follows a positive recommendation for NovoEight from the European Medicines Agency (EMA) made last month.

  • EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK EMA backs drugs from Novo, Otsuka, AZ, Janssen, GSK

    Novo Nordisk's haemophilia drug. Among the drugs backed by the CHMP, which provides guidance to the European Medicines Agency (EMA), was Novo Nordisk's NovoEight (turoctocog alfa) for use in ... NovoEight has also been filed for approval in the US, Japan,

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics